Summary
- Current Price
- As of today, JANX price is $16.06, down -11.66% on
- Current Price All-Time High
- JANX price is currently -77.60% below its historical high of $71.71 set on
- Market Cap
- JANX current market cap is $982M, down -40.70% year-over-year
- Revenue
- JANX current annual revenue is $10.00M, down -5.55% year-over-year
- Next Earnings
- The next earnings release for JANX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Janux Therapeutics, Inc. |
| Ticker | NASDAQ: JANX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | januxrx.com |
| Employees | 91 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $16.06 | |
| Price, 1D Change | -11.66% | |
| $982M | ||
| - | ||
| - | ||
| 1.28 | ||
| $10.00M | ||
| Revenue, 1Y Change | -5.55% | |
| -$1.83 | ||
| EPS, 1Y Change | -42.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.83 | ||
| EPS Estimate | -$1.73 | N/A |
| EPS Est. Change | +5.54% | N/A |
| $10.00M | ||
| Revenue Estimate | $29.42M | N/A |
| Revenue Est. Change | +194.24% | N/A |
| Current Price | $16.06 | |
| Price Target | $28.50 | - |
| Price Tgt. Change | +77.46% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.30 | -$1.28 | +1.59% | |
| -$1.97 | -$1.83 | +6.79% | |
| -$1.73 | N/A | +5.54% | |
| -$2.62 | N/A | -43.11% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.44M | $10.59M | -14.88% | |
| $10.07M | $10.00M | -0.66% | |
| $29.42M | N/A | +194.24% | |
| $8.10M | N/A | -19.01% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $16.06 | |
| $15.41 | ||
| $17.52 | ||
| $17.34 | ||
| $17.18 | ||
| $0.01 | ||
| 1.28 | ||
| $0.92 | ||
| 40.36 | ||
| 72.07% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $10.00M | ||
| -$1.83 | ||
| $0.00 | ||
| 79.71% | ||
| -$157.67M | ||
| -1,576.67% | ||
| -$113.63M | ||
| -1,136.25% | ||
| -$155.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 39.04 | ||
| 39.04 | ||
| - | ||
| - | ||
| 12.27 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 40.91 | ||
| 1.06 | ||
| -0.23 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $956.82M | ||
| $966.57M | ||
| $1.01B | ||
| $975.89M | ||
| $50.70M | ||
| $25.00M | ||
| $22.14M | ||
| $2.39M | ||
| $4.97M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $123.63M | ||
| $165.64M | ||
| $2.03M | ||
| $41.77M | ||
| $2.03M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$82.24M | ||
| -$300.98M | ||
| $4.95M | ||
| $1.04M | ||
| -$83.28M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wolfe Research | → | |
| Guggenheim | → | |
| Wedbush | → | |
| Piper Sandler | → | |
| Guggenheim | → | |
| Jones Trading | → | |
| Barclays | → | |
| UBS | → | |
| Guggenheim | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
No data
Screeners with JANX
FAQ
- What is the ticker symbol for Janux Therapeutics, Inc.?
- The ticker symbol for Janux Therapeutics, Inc. is NASDAQ:JANX
- Does Janux Therapeutics, Inc. pay dividends?
- No, Janux Therapeutics, Inc. does not pay dividends
- What sector is Janux Therapeutics, Inc. in?
- Janux Therapeutics, Inc. is in the Healthcare sector
- What industry is Janux Therapeutics, Inc. in?
- Janux Therapeutics, Inc. is in the Biotechnology industry
- What country is Janux Therapeutics, Inc. based in?
- Janux Therapeutics, Inc. is headquartered in United States
- When did Janux Therapeutics, Inc. go public?
- Janux Therapeutics, Inc. initial public offering (IPO) was on June 11, 2021
- Is Janux Therapeutics, Inc. in the S&P 500?
- No, Janux Therapeutics, Inc. is not included in the S&P 500 index
- Is Janux Therapeutics, Inc. in the NASDAQ 100?
- No, Janux Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Janux Therapeutics, Inc. in the Dow Jones?
- No, Janux Therapeutics, Inc. is not included in the Dow Jones index
- When was Janux Therapeutics, Inc. last earnings report?
- Janux Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Janux Therapeutics, Inc. report earnings?
- The next expected earnings date for Janux Therapeutics, Inc. is November 5, 2026
Data Sources & References
- JANX Official Website www.januxrx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1817713/000119312526076918/0001193125-26-076918-index.htm
- JANX Profile on Yahoo Finance finance.yahoo.com/quote/JANX
- JANX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/janx